γδ T cells have been extensively studied in the context of IBD, both in animal models and patients, as playing a protective role through the production of interleukin (IL)-17A, which is important in regulating intestinal barrier permeability (14). This evidence concerns the gene IL17A and inflammatory bowel disease.